Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Development of a Definition of Postacute Sequelae of SARS-CoV-2 Infection

JAMA(2023)10.1001/jama.2023.8823Source: DataRank Database

Development of a Definition of Postacute Sequelae of SARS-CoV-2 Infection is a research paper published in JAMA (2023). On theSindex it has a DataRank of 10.9. It has been cited 865 times, with 200 citing works in its 1-hop citation network.

N/A

10.9DataRank · unranked

Scored on demand from live citation data

Open Access865 citations · 200 citing works in its network

Download PDF

Cite:

Linked data & code

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (28 grants)Impact (FWCI 136.61)OA: bronzeTopics (37)Linked Datasets (24)DataCite Reuse (24)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (2/2)

Has DOI
Indexed in repositories

Accessible (1/2)

Open Access

Interoperable (2/2)

DataCite relations
Linked datasets

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

DataRank Breakdown

Base Score 9%Citation Network 91%

Base Score Contribution

1.0

From this paper's citation signal

Citation Network Contribution

9.9

From 200 citing papers with measurable signal

Learn more about DataRank methodology →

Top 5 citers driving the network score

Ranked by each citer's contribution to N(p) — log1p(C_q) divided by its reference count — out of 200 citers.

Disentangling the Postacute Sequelae of SARS-CoV-2
JAMA202322 citations8 referencesContributes 0.392
Absence of Association between a Long COVID and Severe COVID-19 Risk Variant of FOXP4 and Lung Cancer
Frontiers in Genetics20239 citations6 referencesContributes 0.384
Olfactory and Gustatory Function 3 Years After Mild COVID-19—A Cohort Psychophysical Study
JAMA Otolaryngology–Head & Neck Surgery202318 citations8 referencesContributes 0.368
Long Covid Defined
New England Journal of Medicine2024330 citations21 referencesContributes 0.276
Long COVID: answers emerge on how many people get better
Nature202311 citations9 referencesContributes 0.276

Authors (100)

Sarah E. Jolley ORCID,Elizabeth W. Karlson ORCID,Emily B. Levitan ORCID,Bruce D. Levy ORCID,Grace A. McComsey ORCID

Live enrichment

PubMed:37278994 PMC:PMC10214179 OpenAlex:https://openalex.org/W4378212766

NIAID NIH HHS

Grant: K23 AI159518

NHLBI NIH HHS

Grant: OT2 HL156812

NICHD NIH HHS

Grant: UG1 HD040544

NCATS NIH HHS

Grant: UL1 TR002319

NCATS NIH HHS

Grant: UM1 TR004409

NIAID NIH HHS

Grant: K23 AI146268

NHLBI NIH HHS

Grant: OT2 HL161841

NICHD NIH HHS

Grant: UG1 HD027869

NICHD NIH HHS

Grant: UG1 HD040500

NIAID NIH HHS

Grant: K23 AI157875

NHLBI NIH HHS

Grant: R01 HL162373

NCATS NIH HHS

Grant: UL1 TR004419

NCATS NIH HHS

Grant: UM1 TR004528

NIAID NIH HHS

Grant: L30 AI147159

NIH HHS

Grant: S10 OD030463

NCATS NIH HHS

Grant: UL1 TR002538

NIAID NIH HHS

Grant: L30 AI126521

NIA NIH HHS

Grant: P30 AG072946

NIDDK NIH HHS

Grant: R01 DK130351

NHLBI NIH HHS

Grant: R01 HL161386

NIH HHS

Grant: S10 OD026880

NIGMS NIH HHS

Grant: U54 GM115428

NHLBI NIH HHS

Grant: OT2 HL161847

NICHD NIH HHS

Grant: UG1 HD027915

NICHD NIH HHS

Grant: UG1 HD087192

NICHD NIH HHS

Grant: U10 HD040500

NICHD NIH HHS

Grant: UG1 HD087230

NCATS NIH HHS

Grant: UL1 TR001863

FWCI

136.61

Citation Percentile

1.0%

Citation Trend

2013

2022

2023

2024

2025

2026

bronze

journalhttps://jamanetwork.com/journals/jama/articlepdf/2805540/jama_thaweethai_2023_oi_230062_1686240966.39381.pdf

publisherhttps://jamanetwork.com/journals/jama/articlepdf/2805540/jama_thaweethai_2023_oi_230062_1686240966.39381.pdf

publisherhttps://jamanetwork.com/journals/jama/articlepdf/2805540/jama_thaweethai_2023_oi_230062_1712695240.78274.pdf

journalhttps://doi.org/10.1001/jama.2023.8823

repositoryhttps://pubmed.ncbi.nlm.nih.gov/37278994

Fields of Study

Long-Term Effects of COVID-19Fibromyalgia and Chronic Fatigue Syndrome ResearchRespiratory and Cough-Related ResearchFemaleAdultHumansMiddle AgedMaleSARS-CoV-2COVID-19Prospective StudiesPost-Acute COVID-19 SyndromeCohort StudiesDisease ProgressionFatigue

MeSH Terms

COVID-19SARS-CoV-2Post-Acute COVID-19 SyndromeAdultFatigueFemaleHumansMaleMiddle AgedProspective StudiesCohort StudiesDisease Progression

Keywords

MedicineSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Coronavirus disease 2019 (COVID-19)VirologyBetacoronavirus2019-20 coronavirus outbreakPathologyDiseaseInfectious disease (medical specialty)Outbreak

Sustainable Development Goals

SDG 0: Good health and well-being

Additional file 1 of Prevalence and predictors of post-COVID-19 symptoms in general practice - a registry-based nationwide study

10.6084/m9.figshare.24439240.v1figshare

Additional file 1 of Prevalence and predictors of post-COVID-19 symptoms in general practice - a registry-based nationwide study

10.6084/m9.figshare.24439240figshare

Additional file 1 of Development and validation of a prognostic model for assessing long COVID risk following Omicron wave—a large population-based cohort study

10.6084/m9.figshare.25951881.v1figshare

Additional file 1 of Development and validation of a prognostic model for assessing long COVID risk following Omicron wave—a large population-based cohort study

10.6084/m9.figshare.25951881figshare

Additional file 2 of Development and validation of a prognostic model for assessing long COVID risk following Omicron wave—a large population-based cohort study

10.6084/m9.figshare.25951965.v1figshare

Additional file 2 of Development and validation of a prognostic model for assessing long COVID risk following Omicron wave—a large population-based cohort study

10.6084/m9.figshare.25951965figshare

Additional file 1 of Long-term health consequences among individuals with SARS-CoV-2 infection compared to individuals without infection: results of the population-based cohort study CoMoLo Follow-up

10.6084/m9.figshare.26611724.v1figshare

Additional file 1 of Long-term health consequences among individuals with SARS-CoV-2 infection compared to individuals without infection: results of the population-based cohort study CoMoLo Follow-up

10.6084/m9.figshare.26611724figshare

Additional file 5 of Genetic risk factors for severe and fatigue dominant long COVID and commonalities with ME/CFS identified by combinatorial analysis

10.6084/m9.figshare.26634663.v1figshare

Additional file 5 of Genetic risk factors for severe and fatigue dominant long COVID and commonalities with ME/CFS identified by combinatorial analysis

10.6084/m9.figshare.26634663figshare

Additional file 1 of Bulk RNA sequencing for analysis of post COVID-19 condition in adolescents and young adults

10.6084/m9.figshare.26698274.v1figshare

Additional file 1 of Bulk RNA sequencing for analysis of post COVID-19 condition in adolescents and young adults

10.6084/m9.figshare.26698274figshare

Additional file 1 of A pilot randomized controlled trial of a telemedicine psychosocial intervention to improve symptom management in adults with long COVID: the COPE study protocol

10.6084/m9.figshare.26734818.v1figshare

Additional file 1 of A pilot randomized controlled trial of a telemedicine psychosocial intervention to improve symptom management in adults with long COVID: the COPE study protocol

10.6084/m9.figshare.26734818figshare

Additional file 2 of A pilot randomized controlled trial of a telemedicine psychosocial intervention to improve symptom management in adults with long COVID: the COPE study protocol

10.6084/m9.figshare.26734821.v1figshare

Additional file 2 of A pilot randomized controlled trial of a telemedicine psychosocial intervention to improve symptom management in adults with long COVID: the COPE study protocol

10.6084/m9.figshare.26734821figshare

Additional file 4 of Genetic risk factors for severe and fatigue dominant long COVID and commonalities with ME/CFS identified by combinatorial analysis

10.6084/m9.figshare.26634660figshare

Additional file 3 of Genetic risk factors for severe and fatigue dominant long COVID and commonalities with ME/CFS identified by combinatorial analysis

10.6084/m9.figshare.26634657figshare

Additional file 4 of Genetic risk factors for severe and fatigue dominant long COVID and commonalities with ME/CFS identified by combinatorial analysis

10.6084/m9.figshare.26634660.v1figshare

Additional file 2 of Genetic risk factors for severe and fatigue dominant long COVID and commonalities with ME/CFS identified by combinatorial analysis

10.6084/m9.figshare.26634654.v1figshare